Keyword Tag Sort by


Categories: Breast Cancer Magnetic resonance imaging MRI

MRI may cause more harm than good in newly diagnosed early breast cancer

ANN ARBOR, Mich. -- A new review says using magnetic resonance imaging (MRI) before surgery to assess the extent of early breast cancer has not been shown to improve surgical planning, reduce follow-up surgery, or reduce the risk of local recurrences.

The review, appearing early online in CA: A Cancer Journal for Clinicians, says evidence shows that MRI increases the chances of more extensive surgery over conservative approaches, with no evidence that it improves surgical care or prognosis.

Randomized controlled trials have shown women with early stage breast cancer who are treated with breast-conservation therapy (lumpectomy followed by radiation) have the same survival rates as those who undergo mastectomy. Recently, MRI has been introduced in preoperative staging of the affected breast in women with newly diagnosed breast cancer because it detects additional areas of cancer that do not show up on conventional imaging.

In the current review, Nehmat Houssami, MBBS, Ph.D., of the University of Sydney, Australia, and Daniel F. Hayes, M.D., director of the breast oncology program at the University of Michigan Comprehensive Cancer Center, reviewed available data on preoperative MRI’s detection capability and its impact on treatment.

The use of preoperative MRI scans in women with early stage breast cancer has been based on assumptions that MRI’s detection capability in this setting will improve surgical treatment by improving surgical planning, potentially leading to a reduction in re-excision surgery, and by guiding surgeons to remove additional disease detected by MRI and potentially reducing  recurrence in the treated breast. The authors say emerging data show that this approach to local staging of the breast leads to more women being treated with mastectomy without evidence of improvement in surgical outcomes or long-term prognosis.

After reviewing the data, the authors conclude that there is evidence that MRI changes surgical management, generally from breast conservation to more radical surgery, but that there is no evidence that it improves surgical treatment or outcomes.

 

 

MRI may cause more harm than good in newly diagnosed early breast cancer Daniel F. Hayes, M.D., director of the breast oncology program

“Overall, there is growing evidence that MRI does not improve surgical care, and it could be argued that it has a potentially harmful effect,” conclude the authors. They say well-designed, randomized controlled trials are needed to quantify potential benefit and harm, including careful evaluation of its impact on quality of life.

“We acknowledge that logistics and costs of conducting such large-scale, multicenter trials are enormous. If the technology is truly as beneficial as its proponents claim, then these costs are worth it. If it is not, then they are outweighed by the costs of adopting expensive technology and associated intervention without evidence of clinical benefit,” they conclude.

Contact: Nicole Fawcett, E-mail: nfawcett@umich.edu, Phone: 734-764-2220

Source: University of Michigan Health System

Related News:

Stem Cells for Metastasis Found in Blood of Breast Cancer Patients 30 April 2013, 08:43
For the first time, scientists from the German Cancer Research Center (DKFZ) and the National...

Less Invasive Treatment is Associated with Improved Survival in... 28 January 2013, 09:03
DURHAM, N.C. -- Patients with early stage breast cancer who were treated with lumpectomy plus...

Diverse Genetic Alterations Found in Triple-negative Breast Cancers... 7 December 2012, 06:01
Residual tumor cells are found in up to 70 percent of these patients. Multiple types of...

Combination therapy with experimental drug improves outlook for... 5 December 2012, 08:08
A combination therapy using an experimental new drug shows significant promise for women with a...

New Insights on Control of Pituitary Hormone Outside of Brain has... 2 October 2012, 04:23
PHILADELPHIA — The hormone prolactin is produced by the pituitary gland in the brain and then...

Comprehensive genomic analysis sheds new light on subtypes of... 24 September 2012, 10:23
HOUSTON -- (September 24, 2012) -- Comprehensive genomic analysis of breast tumors revealed four...

Study reveals genomic similarities between breast cancer and... 24 September 2012, 03:19
UCSC bioinformatics team makes important contributions to breast cancer study from The Cancer...

Study Shows Brain Function Differences in Women with Anorexia 17 September 2012, 05:28
A new study published in Social Cognitive and Affective Neuroscience by researchers at the Center...

Protein Linked to Therapy Resistance in Breast Cancer 12 September 2012, 04:26
Berkeley Lab Researchers Identify Possible New Oncogene and Future Therapy Target.A gene that may...

TRPM7 Protein Key to Breast Cancer Metastasis in Animal Models 11 August 2012, 12:48
In a mouse xenograft model, TRPM7 drives breast cancer cell metastasis. Class of proteins...